These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22393543)

  • 1. The Reason for Regimen Change Among HIV/AIDS Patients Initiated on First Line Highly Active Antiretroviral Therapy in Southern Ethiopia.
    Woldemedhin B; Wabe NT
    N Am J Med Sci; 2012 Jan; 4(1):19-23. PubMed ID: 22393543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.
    Birlie B; Braekers R; Awoke T; Kasim A; Shkedy Z
    BMC Infect Dis; 2017 Jun; 17(1):453. PubMed ID: 28655306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes for antiretroviral regimen change among HIV/AIDS patients in Addis Ababa, Ethiopia.
    Jima YT; Angamo MT; Wabe NT
    Tanzan J Health Res; 2013 Jan; 15(1):11-8. PubMed ID: 26591668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India.
    Kumarasamy N; Vallabhaneni S; Cecelia AJ; Yepthomi T; Balakrishnan P; Saghayam S; Flanigan TP; Carpenter CC; Solomon S; Mayer KH
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):53-8. PubMed ID: 16340473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIVinfected Persons.
    Adedeji TA; Adebisi SA; Adedeji NO
    Infect Disord Drug Targets; 2020; 20(3):374-384. PubMed ID: 31389318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
    Kumarasamy N; Venkatesh KK; Cecelia AJ; Devaleenal B; Lai AR; Saghayam S; Balakrishnan P; Yepthomi T; Poongulali S; Flanigan TP; Solomon S; Mayer KH
    AIDS Patient Care STDS; 2008 Apr; 22(4):337-44. PubMed ID: 18422462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of anti-retroviral regimen changes among HIV/AIDS patients of east and west Wollega zone health institutions, Oromia region, west Ethiopia: a cross-sectional study.
    Bokore A; Korme B; Bayisa G
    BMC Pharmacol Toxicol; 2018 Jun; 19(1):28. PubMed ID: 29871665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study.
    French M; Amin J; Roth N; Carr A; Law M; Emery S; Drummond F; Cooper D;
    HIV Clin Trials; 2002; 3(3):177-85. PubMed ID: 12032876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects after HAART Initiation in resource-limited settings: a prospective study from Mysore, India.
    Sreenivasan S; Dasegowda V
    J Infect Dev Ctries; 2010 Nov; 4(11):750-3. PubMed ID: 21252454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.
    Carr A; Chuah J; Hudson J; French M; Hoy J; Law M; Sayer D; Emery S; Cooper DA
    AIDS; 2000 Jun; 14(9):1171-80. PubMed ID: 10894281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort Analysis.
    Sun J; Liu L; Shen J; Qi T; Wang Z; Song W; Zhang R; Lu H
    PLoS One; 2015; 10(7):e0133242. PubMed ID: 26207639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children.
    Buck WC; Kabue MM; Kazembe PN; Kline MW
    J Int AIDS Soc; 2010 Aug; 13():31. PubMed ID: 20691049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
    Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
    BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
    Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude and predictors of first-line antiretroviral therapy regimen change among HIV infected adults: A retrospective cross sectional study.
    Alema NM; Asgedom SW; Maru M; Berihun B; Gebrehiwet T; Atey TM; Demsie DG; Bantie AT; Yehualaw A; Taferre C; Seid SA; Girma T; Allene MD; Tamru SM
    Ann Med Surg (Lond); 2022 Sep; 81():104303. PubMed ID: 36147157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Saekang N; Pairoj W; Chantratita W
    J Clin Virol; 2008 Apr; 41(4):310-3. PubMed ID: 18316243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.
    Li T; Guo F; Li Y; Zhang C; Han Y; Lye W; He Y; Lu H; Xie J; Huang A; Li Y; Tang X; Wang H; Zhang T; Gao G; Lei J; Zhang X; Wu X; Sun Y; Bai J; Luo L; Wang H
    Chin Med J (Engl); 2014; 127(1):59-65. PubMed ID: 24384425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
    Humphreys EH; Hernandez LB; Rutherford GW
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006517. PubMed ID: 17943914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.